New Patented Medicines Reported to PMPRB

Up to date as of October 15, 2021

Search by:

to

* Note: Drugs with Price Review Records linked from the brand name are only available from 2010 onward (records for 2011 will be populated over the next few months). Summary Reports are available for drug products reported prior to 2010.


YearCompanyBrand NameChemical NameDINTherapeutic UseDate of First SaleStatus
2020AbbvieRinvoq - 15 mg/tabletupadacitinib02495155Rheumatoid arthritis16 Jan 2020Within Guidelines
2020AbbvieHumira - 20 mg/syringeadalimumab02474263Rheumatoid arthritis18 Aug 2020Under Review
2020Advanced Accelerator ApplicationsNetspot - 40 mcg/kitoxodotreotide02490005Cancer11 Dec 2019Under Review
2020ALK-Abello A SItulatek - 12 unit/tabletStandardized Allergen Extract, White Birch (Betula Verrucosa) 02498073Allergy Immunotherapy30 Sep 2020Under Review
2020Alnylam Pharmaceuticals, IncGivlaari - 189 mg/mLgivosiran02506343Acute hepatic porphyria01 Dec 2020Under Review
2020Amgen Canada Inc.Kanjinti - 420 mg/vialtrastuzumab02496690Cancer16 Apr 2020Within Guidelines
2020Aralez Pharmaceuticals Inc.Suvexx 85/500 - 585 mg/tabletsumatriptan/naproxen sodium02496305Migraine24 Aug 2020Under Review
2020Astellas Pharma Canada Inc.Xospata - 40 mg/tabletgilteritinib02495058Cancer04 Feb 2020Subject to Investigation
2020Astrazeneca Canada Inc.Lokelma - 10 g/sachetsodium zirconium cyclosilicate02490722Hyperkalemia17 Oct 2019Subject to Investigation
2020Astrazeneca Canada Inc.Lokelma - 5 g/sachetsodium zirconium cyclosilicate02490714Hyperkalemia17 Oct 2019Subject to Investigation
2020Bausch Health, Canada Inc.Duobrii 0.1/0.45 - 0.55 mg/mLhalobetasol Propionate/Tazarotene02499967Moderate-to-severe plaque psoriasis04 Aug 2020Under Review
2020Bayer Inc.Nubeqa - 300 mg/tabletdarolutamide02496348Cancer24 Mar 2020Within Guidelines
2020Bayer Inc.Nubeqa - 300 mg/tabletdarolutamide02496348Cancer24 Mar 2020Within Guidelines
2020Bayer Inc.Jiviantihemophilic factor (recombinant, b-domain deleted, pegylated)02481766Hemophilia A08 Apr 2020Within Guidelines
2020Bayer Inc.Jiviantihemophilic factor (recombinant, b-domain deleted, pegylated)02481774Hemophilia A11 Mar 2020Within Guidelines
2020Bayer Inc.Jiviantihemophilic factor (recombinant, b-domain deleted, pegylated)02481782Hemophilia A27 Jan 2020Within Guidelines
2020Bayer Inc.Jiviantihemophilic factor (recombinant, b-domain deleted, pegylated)02481790Hemophilia A27 Jan 2020Within Guidelines
2020Bayer Inc.Eylea - 40 mg/mLaflibercept02505355Neovascular (wet) age-related macular degeneration17 Nov 2020Within Guidelines
2020Bayer Inc.Vitrakvi - 100 mg/capsulelarotrectinib02490323Cancer17 Nov 2020Under Review
2020Biomarin Pharmaceutical Canada Inc.Kuvan - 100 mg/sachetsapropterin dihydrochloride02482207Phenylketonuria 05 Dec 2019Within Guidelines
2020Biomarin Pharmaceutical Canada Inc.Kuvan - 500 mg/sachetsapropterin dihydrochloride02482215Phenylketonuria 05 Dec 2019Within Guidelines
2020Celgene IncZeposia - 0.92 mg/capsuleozanimod02505991Multiple sclerosis12 Nov 2020Under Review
2020Celgene IncZeposia 0.23/0.46 - 1 N.A./kitozanimod02506009Multiple sclerosis12 Nov 2020Under Review
2020Celgene IncReblozyl - 25 mg/vialluspatercept02505541beta-thalassemia23 Nov 2020Under Review
2020Celgene IncReblozyl - 75 mg/vialluspatercept02505568beta-thalassemia23 Nov 2020Under Review
2020Chiesi USA, Inc.Cleviprex - 0.5 mg/mLclevidipine02366223Hypertension10 Dec 2019Subject to Investigation
2020Eisai LimitedDayvigo - 5 mg/tabletlemborexant02507366Insomnia06 Nov 2020Under Review
2020Eisai LimitedDayvigo - 10 mg/tabletlemborexant02507374Insomnia06 Nov 2020Under Review
2020Eli Lilly Canada Inc.Lartruvo - 190 mg/vialolaratumab02480271Cancer09 Jun 2020Under Review
2020Gilead Sciences Canada IncVelkury - 100 mg/vialremdesivir02502143COVID-1916 Oct 2020Under Review
2020Glaxosmithkline Inc.Zejula - 100 mg/capsuleniraparib tosylate02489783Cancer09 Jan 2020Subject to Investigation
2020Hoffmann-La Roche LimitedRozlytrek - 200 mg/capsuleentrectinib capsules02495015Cancer03 Jun 2020Under Review
2020Hoffmann-La Roche LimitedEnspryng - 120 mg/mLsatralizumab02499681neuromyelitis optica spectrum disorders18 Sep 2020Under Review
2020Hoffmann-La Roche LimitedPolivy - 140 mg/vial polatuzumab vedotin02499614Cancer25 Nov 2020Under Review
2020Janssen Inc.Darzalex SC - 120 mg/mLdaratumumab injection02502712Multiple myeloma21 Aug 2020Under Review
2020Janssen Inc.Balversa - 3 mg/tableterdafitinib02493217Cancer16 Dec 2019Within Guidelines
2020Janssen Inc.Balversa - 4 mg/tableterdafitinib02493225Cancer11 Dec 2019Within Guidelines
2020Janssen Inc.Balversa - 5 mg/tableterdafitinib02493233Cancer16 Dec 2019Within Guidelines
2020Novartis Pharmaceuticals Canada Inc.Atectura Breezhaler 150/160 - 310 mcg/capsuleindacaterol acetate / mometasone furoate02498707Asthma19 Aug 2020Under Review
2020Novartis Pharmaceuticals Canada Inc.Atectura Breezhaler 150/320 - 470 mcg/capsuleindacaterol acetate / mometasone furoate02498693Asthma19 Aug 2020Under Review
2020Novartis Pharmaceuticals Canada Inc.Atectura Breezhaler 150/80 - 230 mcg/capsuleindacaterol acetate / mometasone furoate02498685Asthma19 Aug 2020Under Review
2020Novartis Pharmaceuticals Canada Inc.Beovu - 120 mg/mLbrolucizumab02496976Neovascular (wet) age-related macular degeneration15 May 2020Does Not Trigger Investigation
2020Novartis Pharmaceuticals Canada Inc.Mayzent - 0.25 mg/tabletsiponimod02496429Multiple sclerosis24 Apr 2020Within Guidelines
2020Novartis Pharmaceuticals Canada Inc.Mayzent - 2 mg/tabletsiponimod02496437Multiple sclerosis24 Apr 2020Within Guidelines
2020Novartis Pharmaceuticals Canada Inc.Enerzair Breezhaler 150/50/160 - 360 mcg/capsuleindacaterol acetate / glycopyrronium bromide / mometasone furoate02501244Asthma05 Nov 2020Under Review
2020Novartis Pharmaceuticals Canada Inc.Piqray - 150 mg/tabletalpelisib02497069Cancer29 Jun 2020Under Review
2020Novartis Pharmaceuticals Canada Inc.Piqray - 250 mg/tabletalpelisib02497077Cancer29 Jun 2020Under Review
2020Novartis Pharmaceuticals Canada Inc.Piqray 50/200 - 250 mg/tabletalpelisib02497085Cancer29 Jun 2020Under Review
2020Novartis Pharmaceuticals Canada Inc.Zolgensmaonasemnogene abeparvovec02509695Spinal Muscular Atrophy22 Sep 2020Under Review
2020Pfizer Canada Inc. Ibrance - 75 mg/tabletpalbociclib02493535Cancer21 Sep 2020Under Review
2020Pfizer Canada Inc. Ibrance - 100 mg/tabletpalbociclib02493543Cancer21 Sep 2020Under Review
2020Pfizer Canada Inc. Ibrance - 125 mg/tabletpalbociclib02493551Cancer21 Sep 2020Under Review
2020Pfizer Canada Inc. GENOTROPIN MiniQuick - 0.2 MG/syringe somatropin02401746Growth hormone deficiency17 Sep 2020Under Review
2020Pfizer Canada Inc. GENOTROPIN MiniQuick - 0.4 MG/syringe somatropin02401754Growth hormone deficiency17 Sep 2020Under Review
2020Pfizer Canada Inc.Vyndaqel - 20 mg/capsuletafamidis meglumine02495732Heart13 Apr 2020Within Guidelines
2020Sanofi-Aventis Canada Inc.Toujeo DoubleStar - 300 unit/mLinsulin glargine02493373Type 2 diabetes mellitus04 Feb 2020Within Guidelines
2020Sanofi-Aventis Canada Inc.Sarclisa - 100 mg/vialisatuximab02498235Multiple myeloma03 Jul 2020Under Review
2020Sanofi-Aventis Canada Inc.Sarclisa - 500 mg/vialisatuximab02498243Multiple myeloma03 Jul 2020Under Review
2020Seattle Genetics Inc.Tukysa - 150 mg/tablet - 0.55 mg/mLtucatinib02499835Cancer27 Aug 2020Under Review
2020Seattle Genetics Inc.Tukysa - 50 mg/tablettucatinib02499835Cancer08 Oct 2020Under Review
2020Sunovion Pharmaceuticals Canada Inc.Kynmobi - 10 mg/filmapomorphine hydrochloride02500264Parkinson's disease17 Nov 2020Within Guidelines
2020Sunovion Pharmaceuticals Canada Inc.Kynmobi - 15 mg/filmapomorphine hydrochloride02500272Parkinson's disease17 Nov 2020Within Guidelines
2020Sunovion Pharmaceuticals Canada Inc.Kynmobi - 20 mg/filmapomorphine hydrochloride02500280Parkinson's disease17 Nov 2020Within Guidelines
2020Sunovion Pharmaceuticals Canada Inc.Kynmobi - 25 mg/filmapomorphine hydrochloride02500299Parkinson's disease17 Nov 2020Within Guidelines
2020Sunovion Pharmaceuticals Canada Inc.Kynmobi - 30 mg/filmapomorphine hydrochloride02500302Parkinson's disease17 Nov 2020Within Guidelines
2020Tahio Pharma CanadaInqovi 35/100 - 135 mg/tabletdecitabine /cedazuridine02501600myelodysplastic syndromes11 Nov 2020Under Review
2020Takeda Canada Inc.Adynovate - 3000 IU/vialantihemophilic Factor (Recombinant), PEGylated02498626Hemophilia A15 Sep 2020Under Review
2020Takeda Canada Inc.Entyvio - 108 mg/penvedolizumab02497867Ulcerative colitis08 Jul 2020Under Review
2020Takeda Canada Inc.Entyvio - 108 mg/syringevedolizumab02497875Ulcerative colitis20 Nov 2020Under Review
2020Teva Canada Innovation G.P.-S.E.N.CAermony Respiclick - 55 mcg/actuationfluticasone propionate02467895Asthma30 Sep 2020Under Review
2020Teva Canada Innovation G.P.-S.E.N.CAermony Respiclick - 113 mcg/actuation fluticasone propionate02467909Asthma30 Sep 2020Under Review
2020Teva Canada Innovation G.P.-S.E.N.CAermony Respiclick - -232 mcg/actuation fluticasone propionate02467917Asthma30 Sep 2020Under Review
2020Teva Canada Innovation G.P.-S.E.N.C.Ajovy - 150 mg/mLfremanezumab02497859Migraine04 Aug 2020Under Review
2020UCB Canada Inc.Brivlera - 10 mg/mLbrivaracetam02452987Epilepsy06 Apr 2020Within Guidelines
2020Vertex Pharmaceuticals Canada Inc.elexacaftor/tezacaftor/ivacaftor and ivacaftor - 1 N.A./packelexacaftor/tezacaftor/ivacaftor and ivacaftorCystic fibrosis 22 Jan 2020Under Review
2020Viiv Healthcare UlcCabenuva 200/300 - 500 mg/mLcabotegravir/rilpivirine02497220HIV21 Sep 2020Under Review
2020Viiv Healthcare UlcCabenuva 200/300 - 500 mg/mLcabotegravir/rilpivirine02497247HIV21 Sep 2020Under Review
2020Viiv Healthcare UlcVocabria - 30 mg/tabletcabotegravir02497204HIV21 Sep 2020Under Review